BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27238707)

  • 1. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.
    Benton SJ; McCowan LM; Heazell AE; Grynspan D; Hutcheon JA; Senger C; Burke O; Chan Y; Harding JE; Yockell-Lelièvre J; Hu Y; Chappell LC; Griffin MJ; Shennan AH; Magee LA; Gruslin A; von Dadelszen P
    Placenta; 2016 Jun; 42():1-8. PubMed ID: 27238707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction.
    Shinar S; Tigert M; Agrawal S; Parks WA; Kingdom JC
    Pregnancy Hypertens; 2021 Aug; 25():123-128. PubMed ID: 34119877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
    Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
    Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
    Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
    BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study.
    Gaccioli F; Sovio U; Cook E; Hund M; Charnock-Jones DS; Smith GCS
    Lancet Child Adolesc Health; 2018 Aug; 2(8):569-581. PubMed ID: 30119716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?
    Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
    Am J Obstet Gynecol; 2012 Feb; 206(2):163.e1-7. PubMed ID: 22055338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.
    Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L
    Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
    Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
    Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal Growth and Placental Growth Factor Umbilical Cord Blood Levels.
    Broere-Brown ZA; Schalekamp-Timmermans S; Jaddoe VWV; Steegers EAP
    Fetal Diagn Ther; 2018; 43(1):26-33. PubMed ID: 28926825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
    Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
    Shinohara S; Uchida Y; Kasai M; Sunami R
    Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction.
    Cetin I; Mazzocco MI; Giardini V; Cardellicchio M; Calabrese S; Algeri P; Martinelli A; Todyrenchuk L; Vergani P
    J Matern Fetal Neonatal Med; 2017 Jan; 30(2):144-149. PubMed ID: 27028483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental glucose transporter 1 and 3 gene expression in Monochorionic twin pregnancies with selective fetal growth restriction.
    Chang YL; Chao AS; Chang SD; Cheng PJ
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):260. PubMed ID: 33773574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.